Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · S 4327

Securing America’s Drug Supply from Communist China Act

Refreshed 3 h ago

Introduced 2026-04-16Topic: health care · public health

Summary

AI-generated summary, report an error

This bill would require the Food and Drug Administration to review drug applications from Chinese companies, or companies licensing products owned by Chinese companies, to determine whether the sponsor is supported by or affiliated with the Chinese government, the Chinese Communist Party, or the People's Liberation Army. New applications from affiliated sponsors could not be approved. The agency would also review applications submitted from January 1, 2016, until the bill becomes law. Imported drugs whose sponsor or application holder is found to be affiliated would be refused and destroyed by Customs and Border Protection, unless the company shows it is no longer affiliated, sells the application within 180 days, or a waiver is granted to avoid a drug shortage. The bill authorizes $5,000,000 to carry out these steps.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2026-04-16SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.refer
2026-04-16Introduced in Senateintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-11. Provisions and opinion polling arrive in a later release.